Current Editions
Kate raises the bar for DMD gene therapy
At ASGCT meeting, Westlake and Versant-backed Kate Therapeutics shows its AAV gene therapy targets muscle, heart in primates
Product Development
House Oversight Chair Comer looks to enlist FDA in China rivalry
Former FDA official concerned about unintended consequences of bringing agency into geopolitical competition
Politics, Policy & Law
Finance
Venture report: Big rounds for Bluejay, Attovia and Zenas
Strong fundraising week also included launches by Prologue and Commit, plus raises by Aardvark, Memo and OverT
Management Tracks
C-suite changes at Acelyrin could signal reprioritizations in pipeline
With CEO Shao-Lee Lin leaving, the company said it’s aiming to preserve cash resources, with a series of decision-driving clinical catalysts on the way
Reginald Seeto at the helm of Scipher
Plus: New heads of commercial and strategy at AdvanCell, and an update from Vivodyne
BioCentury ISSN 1097-7201